AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
158 hedge funds and large institutions have $2.19B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 37 increasing their positions, 53 reducing their positions, and 40 closing their positions.
157% more call options, than puts
Call options by funds: $100M | Put options by funds: $38.9M
25% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 40
11% more capital invested
Capital invested by funds: $1.97B → $2.19B (+$221M)
5% more funds holding
Funds holding: 150 → 158 (+8)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
30% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$121M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$80.1M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$79M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$68.6M |
| 5 |
MP
Manikay Partners
New York
|
+$62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$190M |
| 2 |
PC
Paulson & Co
New York
|
-$119M |
| 3 |
JCI
Jet Capital Investors
New York
|
-$62.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$62.1M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$44.6M |
AUXL Hedge Fund Activity: Q4 2014 in Review
158 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2014, worth a combined $2.19B — up 11% from $1.97B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new AUXL positions and 40 closed out — a net gain of 10 holders — while 37 added to existing stakes and 53 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $121M. The largest seller was Fidelity Investments, exiting entirely with an estimated $190M sold.
- 158 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2014, up from 150 in Q3 2014.
- Funds reported $2.19B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2014, up 11% quarter-over-quarter.
- 50 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2014 and 40 closed out, a net change of +10 holders.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2014 was Pentwater Capital Management, an estimated $121M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2014 was Fidelity Investments, an estimated $190M sold.
Based on aggregated 13F filings for Q4 2014.